Certified Release of Information Specialist (CRIS) Certification Practice Test 2026 - Free CRIS Practice Questions and Study Guide

The scenario that illustrates the need for special authorization involves the disclosure of chemical dependency treatment. This is due to the heightened privacy protections that apply to sensitive information regarding substance abuse treatment. Specific regulations, such as those outlined in 42 CFR Part 2, mandate that entities must obtain explicit consent from the patient before sharing information related to chemical dependency treatment. This requirement ensures that individuals receiving treatment for substance use disorders have additional safeguards protecting their privacy, recognizing the stigma and potential legal ramifications that can arise from such disclosures.

In contrast, general medical record copies, routine medical information for educational purposes, and requests from family members without medical consent typically do not necessitate special authorization. These scenarios either involve information that does not have the same level of privacy protection or are governed by broader consent regulations that do not require heightened scrutiny. Thus, the need for special authorization is a critical consideration when dealing with sensitive health information, particularly in the context of chemical dependency.